公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.
公司地址 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
電話號碼 +1 877 352-6261
傳真號碼 --
公司網頁 https://www.elanco.com
員工數量 9400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ramiro Martin Cabral Executive Vice President and President of Elanco International 美元 650.00K 08/04/2026
Mr. David S. Kinard Executive Vice President, Human Resources, Corporate Communications and Administration. -- 08/04/2026
Ms. Ellen de Brabander, PhD Executive Vice President, Innovation and Regulatory Affairs 美元 847.83K 08/04/2026
Mr. Rajeev A. Modi Executive Vice President, U.S. Pet Health and Global Digital Transformation -- 08/04/2026
Mr. Timothy J. Bettington Executive Vice President, Center of Strategic Growth 美元 656.00K 08/04/2026
Ms. Grace McArdle Executive Vice President, Manufacturing and Quality -- 08/04/2026
Mr. James M. Meer Senior Vice President and Chief Accounting Officer -- 08/04/2026
Mr. Robert M. VanHimbergen Executive Vice President and Chief Financial Officer 美元 317.31K 08/04/2026
Ms. Shiv O'Neill Executive Vice President, General Counsel and Corporate Secretary -- 08/04/2026
Mr. Jose Manuel Correia de Simas, PhD Executive Vice President, U.S. Farm Animal Business -- 08/04/2026
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 美元 1.20M 08/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Lawrence E. Kurzius Chairman of the Board 08/04/2026
Dr. Stacey Ma, PhD Independent Director 08/04/2026
Mr. Art A. Garcia Independent Director 08/04/2026
Mr. Kirk McDonald Independent Director 08/04/2026
Ms. Kapila Kapur Anand Independent Director 08/04/2026
Mr. Michael J. Harrington Independent Director 08/04/2026
Mr. R. David Hoover Independent Director 08/04/2026
Mr. Paul S. Herendeen Independent Director 08/04/2026
Dr. Deborah T. Kochevar, D.V.M.,PhD Independent Director 08/04/2026
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 08/04/2026
Dr. Denise Vera Scots-Knight, PhD Independent Director 08/04/2026
 
所屬ETF (更新日期: 02/05/2026 03:58)
代號 名稱 佔比% 持有日期
SMLFiShares U.S. Small-Cap Eq Fac ETF0.04%29/04/2026
FDMOFidelity Momentum Factor ETF0.04%29/04/2026
RECSColumbia Research Enhanced Core ETF0.04%04/02/2026
BBMCJPMorgan BetaBuilders US Mid Cap Eq ETF0.04%29/04/2026
SMMDiShares Russell 2500 ETF0.04%29/04/2026
BSMCBrandes U.S. Small-Mid Cap Value ETF0.04%29/04/2026
USVMVictoryShares US Sm Md Cp Val Momt ETF0.04%29/04/2026
TMSLT. Rowe Price Small-Mid Cap ETF0.04%29/04/2026
JMEEJPMorgan Small & Mid Cap Enh Eq ETF0.03%29/04/2026
FFSMFidelity Fundamental Small-Mid Cap ETF0.03%28/02/2026
FNXFirst Trust Mid Cap Core AlphaDEX® ETF0.03%29/04/2026
DFUSDimensional US Equity Market ETF0.03%29/04/2026
PPHVanEck Pharmaceutical ETF0.03%29/04/2026
VFMOVanguard US Momentum Factor ETF0.03%31/03/2026
PRFInvesco RAFI US 1000 ETF0.03%29/04/2026
IWViShares Russell 3000 ETF0.03%29/04/2026
AVUSAvantis US Equity ETF0.03%29/04/2026
RFGInvesco S&P MidCap 400® Pure Growth ETF0.02%29/04/2026
FNYFirst Trust Mid Cap Growth AlphaDEX® ETF0.02%29/04/2026
ESGVVanguard ESG US Stock ETF0.02%31/03/2026
  1    2   3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.